News
After Decades Without Progress in Glioblastoma, Diakonos Stirs Up Interest in Dendritic Cell Vaccine
The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.
In eight tumors where patients failed immune checkpoint inhibitor (ICI) treatment, Plinabulin + radiation + PD-1 inhibitors demonstrated ...
The pediatric tumor research group of the Cima Universidad de Navarra The combined strategy developed at Cima can overcome the limitations ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback